The increased expression of CXCL12 and CSF1 in senescent CRC tumor cells establishes a cytokine barrier that suppresses immune infiltration by tumor-associated T cells, thereby protecting non-senescent tumor cells from immune attack and promoting resistance to CRC (100) (Figure 2B). The gene discussed is CXCL12; the disease is neoplasm.